Condition: Osteo Arthritis Knee · Sponsor: Istituto Ortopedico Rizzoli
"PRP+HA-23" is a double-blind randomized controlled clinical trial with 1:1:1 allocation. The objective of the study is to evaluate by a randomized controlled, double-blind clinical trial the efficacy and safety of viscosupplementation-associated PRP infiltration compared with PRP-only or HA-only infiltration for the treatment of patients with knee osteoarthritis.
This description comes directly from the study's public registry record.
Davide Reale, MD · 0516366567 · davide.reale@ior.it
Roberta Licciardi, MSc · 0516366567 · roberta.licciardi@ior.it
Always discuss trial participation with your own doctor first.
| IRCCS Istituto Ortopedico Rizzoli | Bologna, Italy | Not Yet Recruiting |
| Istituto Ortopedico Rizzoli | Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06685120